SVT-6A4710
/ Servatus
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 30, 2024
Testing safety and efficacy of a live bacterial therapy for the treatment of active Rheumatoid Arthritis.
(ANZCTR)
- P1/2 | N=80 | Recruiting | Sponsor: Servatus Ltd | N=45 ➔ 80
Enrollment change • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology • CRP
1 to 1
Of
1
Go to page
1